RPS6KB1 and breast cancer: Our previous studies demonstrated that in this context MDA-MB-231 breast cancer cells give rise to locally recurrent disease in 50-70% of cases and that impairment of p70S6K activity, by different means, strongly decreases the rate of recurrence formation of these cells [9,10].